Pre-order Enquiry
Download Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8003 Da.
According to our Researcher latest study, the global Low Molecular Weight Heparin (LMWHs) market size was valued at USD 348.4 million in 2022 and is forecast to a readjusted size of USD 427.5 million by 2029 with a CAGR of 3.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Low Molecular Weight Heparin main players are Aspen, Sanofi-aventis, CSBIO, Dongying Tiandong Pharmaceutical, Techdow, etc. Top five companies hold a share above 55%. Europe is the largest market, with a share about 38%.
This report is a detailed and comprehensive analysis for global Low Molecular Weight Heparin (LMWHs) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Low Molecular Weight Heparin (LMWHs) market size and forecasts, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Low Molecular Weight Heparin (LMWHs) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Low Molecular Weight Heparin (LMWHs) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Low Molecular Weight Heparin (LMWHs) market shares of main players, shipments in revenue ($ Million), sales quantity (Kiloton), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Low Molecular Weight Heparin (LMWHs)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Low Molecular Weight Heparin (LMWHs) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen, Sanofi-aventis, Pfizer, Opocrin and CSBIO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Low Molecular Weight Heparin (LMWHs) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Market segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Low Molecular Weight Heparin (LMWHs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Low Molecular Weight Heparin (LMWHs), with price, sales, revenue and global market share of Low Molecular Weight Heparin (LMWHs) from 2018 to 2023.
Chapter 3, the Low Molecular Weight Heparin (LMWHs) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Low Molecular Weight Heparin (LMWHs) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Low Molecular Weight Heparin (LMWHs) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Low Molecular Weight Heparin (LMWHs).
Chapter 14 and 15, to describe Low Molecular Weight Heparin (LMWHs) sales channel, distributors, customers, research findings and conclusion.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8003 Da.
According to our Researcher latest study, the global Low Molecular Weight Heparin (LMWHs) market size was valued at USD 348.4 million in 2022 and is forecast to a readjusted size of USD 427.5 million by 2029 with a CAGR of 3.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Low Molecular Weight Heparin main players are Aspen, Sanofi-aventis, CSBIO, Dongying Tiandong Pharmaceutical, Techdow, etc. Top five companies hold a share above 55%. Europe is the largest market, with a share about 38%.
This report is a detailed and comprehensive analysis for global Low Molecular Weight Heparin (LMWHs) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Low Molecular Weight Heparin (LMWHs) market size and forecasts, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Low Molecular Weight Heparin (LMWHs) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Low Molecular Weight Heparin (LMWHs) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Low Molecular Weight Heparin (LMWHs) market shares of main players, shipments in revenue ($ Million), sales quantity (Kiloton), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Low Molecular Weight Heparin (LMWHs)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Low Molecular Weight Heparin (LMWHs) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen, Sanofi-aventis, Pfizer, Opocrin and CSBIO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Low Molecular Weight Heparin (LMWHs) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Market segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
Major players
coveredAspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Low Molecular Weight Heparin (LMWHs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Low Molecular Weight Heparin (LMWHs), with price, sales, revenue and global market share of Low Molecular Weight Heparin (LMWHs) from 2018 to 2023.
Chapter 3, the Low Molecular Weight Heparin (LMWHs) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Low Molecular Weight Heparin (LMWHs) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Low Molecular Weight Heparin (LMWHs) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Low Molecular Weight Heparin (LMWHs).
Chapter 14 and 15, to describe Low Molecular Weight Heparin (LMWHs) sales channel, distributors, customers, research findings and conclusion.
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
